- Dementia and COVID-19 Mortality in South Korea
-
Kyoung DS, Lee J, Nam H, Park MH
- KMID: 2518776
- Dement Neurocogn Disord.
- 2021 Jul;20(3):38-40.
- doi: 10.12779/dnd.2021.20.3.38
-
- CITED
-
- Close
- SHARE
-
- Close
- Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research
-
Kyoung DS, Kim HS
- KMID: 2531862
- J Lipid Atheroscler.
- 2022 May;11(2):103-110.
- doi: 10.12997/jla.2022.11.2.103
Almost every Korean (97%) is enrolled in the National Health Insurance program, and most receive medical treatment at least once a year. Data are collected by the Health Insurance Review... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus
-
Lee SE, Nam H, Choi HS, Kim H, Kyoung DS, Kim KA
- KMID: 2531961
- Diabetes Metab J.
- 2022 Jul;46(4):567-577.
- doi: 10.4093/dmj.2021.0160
Background: Although cardiovascular outcome trials using sodium-glucose cotransporter-2 inhibitors (SGLT-2i) showed a reduction in risk of 3-point major adverse cardiovascular events (MACE), they did not demonstrate beneficial effects on stroke... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
-
Rhee SY, Lee J, Nam H, Kyoung DS, Shin DW, Kim DJ
- KMID: 2514201
- Diabetes Metab J.
- 2021 Mar;45(2):251-259.
- doi: 10.4093/dmj.2020.0206
Background: Dipeptidyl peptidase-4 inhibitor (DPP-4i) and renin-angiotensin system (RAS) blockade are reported to affect the clinical course of coronavirus disease 2019 (COVID-19) in patients with diabetes mellitus (DM). Methods: As of... -
- CITED
-
- Close
- SHARE
-
- Close
